| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 7.36e-11 | 4 | 60 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 7.36e-11 | 4 | 60 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 3.67e-10 | 5 | 60 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.56e-09 | 7 | 60 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 9.17e-09 | 9 | 60 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.53e-08 | 10 | 60 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 5.16e-08 | 13 | 60 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 4.18e-06 | 11 | 60 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.24e-05 | 55 | 60 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 7.24e-05 | 74 | 60 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.20e-04 | 32 | 60 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 1.85e-04 | 7 | 60 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.72e-04 | 42 | 60 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 3.15e-04 | 9 | 60 | 2 | GO:0004690 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 3.93e-04 | 10 | 60 | 2 | GO:0004679 | |
| GeneOntologyMolecularFunction | helicase activity | 1.30e-03 | 158 | 60 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 2.35e-03 | 24 | 60 | 2 | GO:0004407 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 2.55e-03 | 25 | 60 | 2 | GO:0033558 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 3.40e-03 | 337 | 60 | 5 | GO:0031625 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 3.23e-10 | 5 | 60 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.50e-07 | 17 | 60 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.50e-07 | 17 | 60 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.50e-07 | 17 | 60 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.92e-07 | 18 | 60 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 5.50e-07 | 23 | 60 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 1.08e-06 | 27 | 60 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 6.56e-06 | 13 | 60 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 7.03e-06 | 160 | 60 | 6 | GO:0051384 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.05e-05 | 47 | 60 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.58e-05 | 52 | 60 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 1.61e-05 | 185 | 60 | 6 | GO:0031960 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 2.70e-05 | 121 | 60 | 5 | GO:0006576 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 4.97e-05 | 4 | 60 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | NFATC3 KRT27 MICAL2 ACTB PRKACA PRKACB ACTG1 ECSIT DICER1 KRT25 | 5.53e-05 | 750 | 60 | 10 | GO:0048729 |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 6.06e-05 | 73 | 60 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 6.39e-05 | 74 | 60 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 6.39e-05 | 74 | 60 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 7.03e-05 | 619 | 60 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 7.07e-05 | 148 | 60 | 5 | GO:0009308 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 9.55e-05 | 82 | 60 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 9.93e-05 | 31 | 60 | 3 | GO:0098974 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | AURKA UNC5A HDAC6 ACTBL2 ACTB LAMA2 ACTG1 CORO1B DICER1 DSCAML1 | 1.15e-04 | 819 | 60 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | AURKA UNC5A HDAC6 ACTBL2 ACTB LAMA2 ACTG1 CORO1B DICER1 DSCAML1 | 1.23e-04 | 826 | 60 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | cilium disassembly | 1.24e-04 | 6 | 60 | 2 | GO:0061523 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.43e-04 | 35 | 60 | 3 | GO:0099188 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.50e-04 | 684 | 60 | 9 | GO:0010817 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.80e-04 | 286 | 60 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 2.14e-04 | 40 | 60 | 3 | GO:0031069 | |
| GeneOntologyBiologicalProcess | maintenance of blood-brain barrier | 2.48e-04 | 42 | 60 | 3 | GO:0035633 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 2.58e-04 | 106 | 60 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 3.25e-04 | 46 | 60 | 3 | GO:0048730 | |
| GeneOntologyBiologicalProcess | cellular response to parathyroid hormone stimulus | 3.69e-04 | 10 | 60 | 2 | GO:0071374 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 3.69e-04 | 10 | 60 | 2 | GO:0042420 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 4.50e-04 | 11 | 60 | 2 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 4.50e-04 | 11 | 60 | 2 | GO:0019614 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 4.85e-04 | 802 | 60 | 9 | GO:0048812 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 5.29e-04 | 350 | 60 | 6 | GO:0051321 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | AURKA UNC5A HDAC6 CLIC5 ACTBL2 ACTB LAMA2 ACTG1 CORO1B DICER1 DSCAML1 | 5.83e-04 | 1194 | 60 | 11 | GO:0000902 |
| GeneOntologyBiologicalProcess | cellular response to glucagon stimulus | 6.36e-04 | 13 | 60 | 2 | GO:0071377 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 6.36e-04 | 13 | 60 | 2 | GO:0034380 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 6.60e-04 | 365 | 60 | 6 | GO:0006790 | |
| GeneOntologyBiologicalProcess | female meiosis I | 7.40e-04 | 14 | 60 | 2 | GO:0007144 | |
| GeneOntologyBiologicalProcess | response to parathyroid hormone | 7.40e-04 | 14 | 60 | 2 | GO:0071107 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 7.40e-04 | 14 | 60 | 2 | GO:0019336 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 7.58e-04 | 141 | 60 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 7.79e-04 | 142 | 60 | 4 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 7.79e-04 | 142 | 60 | 4 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 7.79e-04 | 142 | 60 | 4 | GO:0034032 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 7.79e-04 | 142 | 60 | 4 | GO:0018958 | |
| GeneOntologyBiologicalProcess | muscle structure development | 7.86e-04 | 858 | 60 | 9 | GO:0061061 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 8.12e-04 | 251 | 60 | 5 | GO:2000241 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 8.25e-04 | 381 | 60 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | PDE3B SULT1A4 HDAC6 SULT1A3 GPR27 NET1 ACTB PRKACA UPF1 IDE CPS1 RYR1 | 8.28e-04 | 1450 | 60 | 12 | GO:1901701 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 8.55e-04 | 531 | 60 | 7 | GO:0042692 | |
| GeneOntologyBiologicalProcess | epithelium development | HDAC3 CLIC5 NFATC3 KRT27 MICAL2 ACTB PRKACA PRKACB ACTG1 CPS1 DICER1 KRT25 | 9.28e-04 | 1469 | 60 | 12 | GO:0060429 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 9.43e-04 | 391 | 60 | 6 | GO:0051146 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.24e-03 | 566 | 60 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | myotube differentiation | 1.33e-03 | 164 | 60 | 4 | GO:0014902 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.39e-03 | 166 | 60 | 4 | GO:0098773 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.39e-03 | 748 | 60 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 1.44e-03 | 752 | 60 | 8 | GO:1901699 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 1.53e-03 | 20 | 60 | 2 | GO:0042402 | |
| GeneOntologyCellularComponent | actin filament | 5.73e-05 | 146 | 59 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 9.99e-05 | 32 | 59 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 9.99e-05 | 32 | 59 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.44e-04 | 94 | 59 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | dense body | 1.63e-04 | 7 | 59 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.13e-04 | 104 | 59 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.55e-04 | 109 | 59 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.79e-04 | 45 | 59 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 3.47e-04 | 10 | 59 | 2 | GO:0005952 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 8.79e-04 | 899 | 59 | 9 | GO:0099513 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 1.15e-03 | 934 | 59 | 9 | GO:0048471 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.15e-03 | 73 | 59 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.30e-03 | 19 | 59 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 1.52e-03 | 972 | 59 | 9 | GO:0140535 | |
| GeneOntologyCellularComponent | supramolecular fiber | AURKA HDAC6 KRT27 MICAL2 ACTBL2 ACTB ACTG1 CORO1B KRT25 RYR1 | 1.57e-03 | 1179 | 59 | 10 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | AURKA HDAC6 KRT27 MICAL2 ACTBL2 ACTB ACTG1 CORO1B KRT25 RYR1 | 1.66e-03 | 1187 | 59 | 10 | GO:0099081 |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.79e-03 | 85 | 59 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 2.44e-03 | 26 | 59 | 2 | GO:0099571 | |
| MousePheno | enlarged gallbladder | 2.16e-06 | 28 | 47 | 4 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 3.76e-06 | 32 | 47 | 4 | MP:0020134 | |
| MousePheno | decreased skeletal muscle fiber number | 4.54e-05 | 21 | 47 | 3 | MP:0009406 | |
| MousePheno | abnormal gallbladder morphology | 4.76e-05 | 60 | 47 | 4 | MP:0005084 | |
| MousePheno | abnormal mammary gland morphology | 5.39e-05 | 201 | 47 | 6 | MP:0000627 | |
| MousePheno | abnormal apocrine gland morphology | 5.39e-05 | 201 | 47 | 6 | MP:0013554 | |
| Domain | ACTINS_1 | 1.41e-06 | 8 | 56 | 3 | PS00406 | |
| Domain | Sulfotransferase_dom | 3.97e-06 | 36 | 56 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 3.97e-06 | 36 | 56 | 4 | PF00685 | |
| Domain | Actin_CS | 1.39e-05 | 16 | 56 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 1.69e-05 | 17 | 56 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.02e-05 | 18 | 56 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.39e-05 | 19 | 56 | 3 | PS01132 | |
| Domain | Actin | 1.08e-04 | 31 | 56 | 3 | IPR004000 | |
| Domain | Actin | 1.08e-04 | 31 | 56 | 3 | PF00022 | |
| Domain | ACTIN | 1.08e-04 | 31 | 56 | 3 | SM00268 | |
| Domain | Hist_deacetyl | 4.77e-04 | 11 | 56 | 2 | PF00850 | |
| Domain | His_deacetylse_dom | 4.77e-04 | 11 | 56 | 2 | IPR023801 | |
| Domain | - | 4.77e-04 | 11 | 56 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 4.77e-04 | 11 | 56 | 2 | IPR000286 | |
| Domain | N2O_reductase_N | 9.04e-04 | 15 | 56 | 2 | IPR011045 | |
| Domain | MAGE | 4.66e-03 | 34 | 56 | 2 | SM01373 | |
| Domain | MAGE | 5.21e-03 | 36 | 56 | 2 | PS50838 | |
| Domain | MAGE | 5.21e-03 | 36 | 56 | 2 | PF01454 | |
| Domain | MHD_dom | 5.21e-03 | 36 | 56 | 2 | IPR002190 | |
| Domain | - | 6.40e-03 | 40 | 56 | 2 | 4.10.1000.10 | |
| Domain | Keratin_I | 7.71e-03 | 44 | 56 | 2 | IPR002957 | |
| Domain | ZnF_C3H1 | 9.12e-03 | 48 | 56 | 2 | SM00356 | |
| Domain | HEAT | 9.12e-03 | 48 | 56 | 2 | PF02985 | |
| Domain | zf-CCCH | 9.49e-03 | 49 | 56 | 2 | PF00642 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 3.74e-10 | 5 | 43 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 5.26e-08 | 13 | 43 | 4 | M18256 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.88e-07 | 90 | 43 | 6 | M835 | |
| Pathway | WP_ESTROGEN_METABOLISM | 5.27e-07 | 22 | 43 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 6.37e-07 | 23 | 43 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 7.63e-07 | 24 | 43 | 4 | M16289 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.67e-06 | 35 | 43 | 4 | M47969 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.71e-06 | 39 | 43 | 4 | MM15695 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 7.00e-06 | 41 | 43 | 4 | M39655 | |
| Pathway | WP_RETINOL_METABOLISM | 9.32e-06 | 44 | 43 | 4 | MM15851 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.64e-05 | 502 | 43 | 9 | MM14537 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.74e-05 | 17 | 43 | 3 | M39483 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 2.12e-05 | 54 | 43 | 4 | M17906 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 4.71e-05 | 66 | 43 | 4 | M101 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 7.39e-05 | 74 | 43 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 7.39e-05 | 74 | 43 | 4 | M39462 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 9.04e-05 | 5 | 43 | 2 | M49034 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 9.04e-05 | 5 | 43 | 2 | M26988 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 9.14e-05 | 29 | 43 | 3 | M45015 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.07e-04 | 156 | 43 | 5 | M39475 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.16e-04 | 83 | 43 | 4 | M8728 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.30e-04 | 261 | 43 | 6 | MM15676 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.35e-04 | 6 | 43 | 2 | MM14628 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.35e-04 | 6 | 43 | 2 | M39437 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.76e-04 | 532 | 43 | 8 | M27870 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 1.89e-04 | 7 | 43 | 2 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.89e-04 | 7 | 43 | 2 | MM15560 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 2.52e-04 | 8 | 43 | 2 | M27840 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.66e-04 | 103 | 43 | 4 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.97e-04 | 106 | 43 | 4 | M27077 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.08e-04 | 107 | 43 | 4 | MM14595 | |
| Pathway | WP_THERMOGENESIS | 3.19e-04 | 108 | 43 | 4 | M39746 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 3.23e-04 | 9 | 43 | 2 | M27877 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.23e-04 | 9 | 43 | 2 | M47725 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.31e-04 | 109 | 43 | 4 | M18788 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 4.03e-04 | 10 | 43 | 2 | M47575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 4.03e-04 | 10 | 43 | 2 | M47648 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.03e-04 | 10 | 43 | 2 | MM15112 | |
| Pathway | REACTOME_DRUG_ADME | 4.62e-04 | 119 | 43 | 4 | MM15692 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 4.91e-04 | 11 | 43 | 2 | MM14732 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 5.88e-04 | 12 | 43 | 2 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 5.88e-04 | 12 | 43 | 2 | M27363 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 5.88e-04 | 12 | 43 | 2 | M15243 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 6.21e-04 | 55 | 43 | 3 | M41823 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME | 6.94e-04 | 13 | 43 | 2 | M29766 | |
| Pathway | WP_DOPAMINE_METABOLISM | 6.94e-04 | 13 | 43 | 2 | M39622 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY | 6.94e-04 | 13 | 43 | 2 | M47723 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY | 6.94e-04 | 13 | 43 | 2 | M47730 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47729 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47726 | |
| Pathway | WP_MAPK_SIGNALING | 8.71e-04 | 246 | 43 | 5 | M39597 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 9.31e-04 | 15 | 43 | 2 | MM15019 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47794 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 9.31e-04 | 15 | 43 | 2 | MM15103 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47504 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 9.31e-04 | 15 | 43 | 2 | MM14965 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 1.01e-03 | 65 | 43 | 3 | M38994 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47645 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.06e-03 | 16 | 43 | 2 | MM14699 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.06e-03 | 16 | 43 | 2 | MM14492 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 1.06e-03 | 16 | 43 | 2 | M923 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.18e-03 | 153 | 43 | 4 | MM15844 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.20e-03 | 17 | 43 | 2 | MM15561 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.20e-03 | 17 | 43 | 2 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.20e-03 | 17 | 43 | 2 | M47544 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 1.20e-03 | 17 | 43 | 2 | M47728 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.20e-03 | 17 | 43 | 2 | MM15215 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.21e-03 | 154 | 43 | 4 | MM15974 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.26e-03 | 70 | 43 | 3 | M12294 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.30e-03 | 157 | 43 | 4 | M4904 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.35e-03 | 18 | 43 | 2 | MM15034 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.35e-03 | 18 | 43 | 2 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.35e-03 | 18 | 43 | 2 | M840 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.50e-03 | 19 | 43 | 2 | M27841 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.58e-03 | 418 | 43 | 6 | MM15587 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.63e-03 | 575 | 43 | 7 | M29853 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 1.65e-03 | 77 | 43 | 3 | M41822 | |
| Pathway | WP_ESTROGEN_SIGNALING | 1.65e-03 | 77 | 43 | 3 | MM15934 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 1.67e-03 | 20 | 43 | 2 | M47737 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.67e-03 | 20 | 43 | 2 | M759 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.84e-03 | 21 | 43 | 2 | M27485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 1.84e-03 | 21 | 43 | 2 | M47722 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 1.84e-03 | 21 | 43 | 2 | M47949 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.98e-03 | 82 | 43 | 3 | M27626 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.19e-03 | 85 | 43 | 3 | M3578 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.19e-03 | 85 | 43 | 3 | M1870 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.21e-03 | 23 | 43 | 2 | MM14954 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 2.40e-03 | 24 | 43 | 2 | M10064 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 2.40e-03 | 24 | 43 | 2 | M27803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.40e-03 | 24 | 43 | 2 | M47520 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.40e-03 | 24 | 43 | 2 | M751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 2.61e-03 | 25 | 43 | 2 | M47716 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 2.82e-03 | 26 | 43 | 2 | M2499 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.82e-03 | 26 | 43 | 2 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.82e-03 | 26 | 43 | 2 | MM14495 | |
| Pathway | PID_IL3_PATHWAY | 2.82e-03 | 26 | 43 | 2 | M182 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.04e-03 | 27 | 43 | 2 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.04e-03 | 27 | 43 | 2 | M47519 | |
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 24318996 | ||
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 8424956 | ||
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 33414449 | ||
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 8943792 | ||
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 8.00e-12 | 4 | 60 | 4 | 12390022 | |
| Pubmed | 8.00e-12 | 4 | 60 | 4 | 25370010 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 11389699 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 29908303 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 24802129 | ||
| Pubmed | 4.00e-11 | 5 | 60 | 4 | 25053625 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 12438748 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 5.57e-10 | 8 | 60 | 4 | 10594240 | |
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 9166597 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 1.00e-09 | 9 | 60 | 4 | 23207770 | |
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 8468045 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 19548878 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.00e-09 | 9 | 60 | 4 | 9060415 | |
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 9177785 | ||
| Pubmed | 1.67e-09 | 10 | 60 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.62e-09 | 11 | 60 | 4 | 7613026 | |
| Pubmed | 2.62e-09 | 11 | 60 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.62e-09 | 11 | 60 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.62e-09 | 11 | 60 | 4 | 9034160 | |
| Pubmed | 2.62e-09 | 11 | 60 | 4 | 10720750 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 3.92e-09 | 12 | 60 | 4 | 7706460 | |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 4.88e-09 | 3 | 60 | 3 | 8363592 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 9855620 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 8912648 | ||
| Pubmed | 5.65e-09 | 13 | 60 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 5.65e-09 | 13 | 60 | 4 | 17425406 | |
| Pubmed | 1.08e-08 | 15 | 60 | 4 | 1741163 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 32152050 | ||
| Pubmed | 2.40e-08 | 18 | 60 | 4 | 20056724 | ||
| Pubmed | 4.68e-08 | 21 | 60 | 4 | 32301970 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 1.65e-07 | 72 | 60 | 5 | 8075499 | |
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 5.81e-07 | 10 | 60 | 3 | 11535246 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.19e-06 | 15 | 60 | 3 | 16824795 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8626720 | ||
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 2.93e-06 | 2 | 60 | 2 | 19638415 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.93e-06 | 2 | 60 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.93e-06 | 2 | 60 | 2 | 22366783 | |
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 2.93e-06 | 2 | 60 | 2 | 14871892 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 2.93e-06 | 2 | 60 | 2 | 3335520 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9288906 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 1577857 | ||
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 2.93e-06 | 2 | 60 | 2 | 3023318 | |
| Pubmed | The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. | 2.93e-06 | 2 | 60 | 2 | 11039908 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.93e-06 | 2 | 60 | 2 | 32588558 | |
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 2.93e-06 | 2 | 60 | 2 | 19965870 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27625340 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 2.93e-06 | 2 | 60 | 2 | 23358261 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26583190 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 32326615 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12180908 | ||
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 2.93e-06 | 2 | 60 | 2 | 38069221 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11207031 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12761191 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 2.93e-06 | 2 | 60 | 2 | 23756437 | |
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 2.93e-06 | 2 | 60 | 2 | 20936502 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31176020 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 10543947 | ||
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 2.93e-06 | 2 | 60 | 2 | 8482333 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8163498 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 2.93e-06 | 2 | 60 | 2 | 7581483 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 29705271 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15752422 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31678302 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 3221869 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20417180 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 29265728 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25307283 | ||
| Pubmed | Systems-level identification of PKA-dependent signaling in epithelial cells. | 2.93e-06 | 2 | 60 | 2 | 28973931 | |
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 2.93e-06 | 2 | 60 | 2 | 22246323 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 36152045 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 38841868 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 2.93e-06 | 2 | 60 | 2 | 10762004 | |
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 2.93e-06 | 2 | 60 | 2 | 8117269 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9566757 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9341190 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 2837653 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22651689 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 32349449 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 37871652 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 2.93e-06 | 2 | 60 | 2 | 32506774 | |
| Pubmed | Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. | 2.93e-06 | 2 | 60 | 2 | 12139926 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8093002 | ||
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 2.93e-06 | 2 | 60 | 2 | 20847274 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 21502360 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12469224 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 6686106 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 213279 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31145702 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 33334799 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 10617600 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16133548 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 2833513 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8033246 | ||
| Interaction | SULT1C2 interactions | 2.32e-07 | 19 | 58 | 4 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 6.29e-07 | 24 | 58 | 4 | int:SULT1A3 | |
| Interaction | ARPC2 interactions | 1.07e-06 | 187 | 58 | 7 | int:ARPC2 | |
| Interaction | TMSB4X interactions | 3.38e-06 | 80 | 58 | 5 | int:TMSB4X | |
| Interaction | LSP1 interactions | 7.01e-06 | 43 | 58 | 4 | int:LSP1 | |
| Interaction | ATF3 interactions | 7.47e-06 | 94 | 58 | 5 | int:ATF3 | |
| Interaction | SULT1A4 interactions | 8.05e-06 | 14 | 58 | 3 | int:SULT1A4 | |
| Interaction | SULT1A2 interactions | 2.12e-05 | 19 | 58 | 3 | int:SULT1A2 | |
| Interaction | PNPLA8 interactions | 2.33e-05 | 58 | 58 | 4 | int:PNPLA8 | |
| Interaction | SULT1A1 interactions | 4.14e-05 | 67 | 58 | 4 | int:SULT1A1 | |
| Interaction | CORO2A interactions | 4.38e-05 | 68 | 58 | 4 | int:CORO2A | |
| Interaction | SULT4A1 interactions | 4.39e-05 | 24 | 58 | 3 | int:SULT4A1 | |
| Interaction | FPR1 interactions | 6.47e-05 | 147 | 58 | 5 | int:FPR1 | |
| Interaction | PHACTR2 interactions | 7.84e-05 | 29 | 58 | 3 | int:PHACTR2 | |
| Interaction | ARPC5L interactions | 7.90e-05 | 79 | 58 | 4 | int:ARPC5L | |
| Interaction | RASA1 interactions | 1.18e-04 | 167 | 58 | 5 | int:RASA1 | |
| Interaction | MYO5C interactions | 1.22e-04 | 168 | 58 | 5 | int:MYO5C | |
| Interaction | GMFB interactions | 1.51e-04 | 36 | 58 | 3 | int:GMFB | |
| Interaction | KRT77 interactions | 1.68e-04 | 96 | 58 | 4 | int:KRT77 | |
| Interaction | DNASE1 interactions | 1.69e-04 | 7 | 58 | 2 | int:DNASE1 | |
| Interaction | FKBP5 interactions | 1.79e-04 | 414 | 58 | 7 | int:FKBP5 | |
| Interaction | PXK interactions | 2.23e-04 | 41 | 58 | 3 | int:PXK | |
| Interaction | PHOX2A interactions | 2.25e-04 | 8 | 58 | 2 | int:PHOX2A | |
| Interaction | SULT1B1 interactions | 2.25e-04 | 8 | 58 | 2 | int:SULT1B1 | |
| Interaction | ERRFI1 interactions | 2.56e-04 | 107 | 58 | 4 | int:ERRFI1 | |
| Interaction | SULT1C4 interactions | 2.84e-04 | 110 | 58 | 4 | int:SULT1C4 | |
| Interaction | HTR1E interactions | 2.89e-04 | 9 | 58 | 2 | int:HTR1E | |
| Interaction | CYBB interactions | 3.14e-04 | 46 | 58 | 3 | int:CYBB | |
| Interaction | ACTR2 interactions | 3.25e-04 | 323 | 58 | 6 | int:ACTR2 | |
| Interaction | DOK2 interactions | 3.48e-04 | 116 | 58 | 4 | int:DOK2 | |
| Interaction | GSN interactions | 3.58e-04 | 212 | 58 | 5 | int:GSN | |
| Interaction | PKIB interactions | 3.61e-04 | 10 | 58 | 2 | int:PKIB | |
| Interaction | MYT1L interactions | 3.61e-04 | 10 | 58 | 2 | int:MYT1L | |
| Interaction | PFN3 interactions | 3.61e-04 | 10 | 58 | 2 | int:PFN3 | |
| Interaction | FAXC interactions | 3.71e-04 | 118 | 58 | 4 | int:FAXC | |
| Interaction | AKAP7 interactions | 3.79e-04 | 49 | 58 | 3 | int:AKAP7 | |
| Interaction | ACTG2 interactions | 3.79e-04 | 49 | 58 | 3 | int:ACTG2 | |
| Interaction | ARPC1B interactions | 3.82e-04 | 215 | 58 | 5 | int:ARPC1B | |
| Cytoband | 17q21.2 | 1.09e-04 | 70 | 60 | 3 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.89e-04 | 473 | 60 | 5 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 4.91e-04 | 278 | 60 | 4 | chr16p11 | |
| Cytoband | 16p12.1 | 4.94e-04 | 25 | 60 | 2 | 16p12.1 | |
| Cytoband | 11q13.2 | 1.75e-03 | 47 | 60 | 2 | 11q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 2.16e-03 | 195 | 60 | 3 | chr10q23 | |
| Cytoband | 17q21.31 | 5.22e-03 | 82 | 60 | 2 | 17q21.31 | |
| GeneFamily | Sulfotransferases, cytosolic | 2.73e-08 | 14 | 43 | 4 | 762 | |
| GeneFamily | Actins | 8.24e-05 | 6 | 43 | 2 | 929 | |
| GeneFamily | UPF1 like RNA helicases | 3.00e-04 | 11 | 43 | 2 | 1169 | |
| GeneFamily | Keratins, type I | 2.01e-03 | 28 | 43 | 2 | 608 | |
| GeneFamily | Zinc fingers CCCH-type | 3.13e-03 | 35 | 43 | 2 | 73 | |
| GeneFamily | MAGE family | 4.07e-03 | 40 | 43 | 2 | 1136 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.08e-03 | 181 | 43 | 3 | 694 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.55e-07 | 24 | 60 | 4 | MM1317 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 1.10e-06 | 147 | 60 | 6 | MM3753 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 1.46e-05 | 135 | 60 | 5 | MM753 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 1.81e-05 | 68 | 60 | 4 | MM770 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.67e-05 | 75 | 60 | 4 | MM1084 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 3.03e-05 | 157 | 60 | 5 | MM1099 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 4.17e-05 | 84 | 60 | 4 | MM873 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 5.13e-05 | 5 | 60 | 2 | M41007 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 9.34e-05 | 199 | 60 | 5 | M6638 | |
| Coexpression | OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP | 1.07e-04 | 7 | 60 | 2 | M41171 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 1.11e-04 | 108 | 60 | 4 | MM1334 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.35e-04 | 856 | 60 | 9 | M4500 | |
| Coexpression | LE_EGR2_TARGETS_DN | 1.52e-04 | 117 | 60 | 4 | MM1139 | |
| Drug | dopamine-4-O-sulfate | 1.32e-09 | 7 | 58 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.32e-09 | 7 | 58 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.32e-09 | 7 | 58 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 1.32e-09 | 7 | 58 | 4 | CID011953812 | |
| Drug | 2-iodophenol | 2.63e-09 | 8 | 58 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 2.63e-09 | 8 | 58 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.63e-09 | 8 | 58 | 4 | CID003037707 | |
| Drug | EM-139 | 2.66e-08 | 13 | 58 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 3.72e-08 | 14 | 58 | 4 | CID000020908 | |
| Drug | deoxoestrone | 3.72e-08 | 14 | 58 | 4 | CID000005888 | |
| Drug | arylsulfate | 5.07e-08 | 15 | 58 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 5.07e-08 | 15 | 58 | 4 | CID000002895 | |
| Drug | A-44 | 6.74e-08 | 16 | 58 | 4 | CID000120353 | |
| Drug | AC1L1IZ2 | 7.19e-08 | 304 | 58 | 9 | CID000004795 | |
| Drug | benzilic acid | 8.80e-08 | 17 | 58 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 1.43e-07 | 19 | 58 | 4 | CID000115063 | |
| Drug | pedunculagin | 1.43e-07 | 19 | 58 | 4 | CID000442688 | |
| Drug | PLP-Glu | 1.78e-07 | 20 | 58 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 2.20e-07 | 21 | 58 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.68e-07 | 22 | 58 | 4 | CID000062244 | |
| Drug | AABSSN | 2.68e-07 | 22 | 58 | 4 | CID005464134 | |
| Drug | taselin | 3.24e-07 | 23 | 58 | 4 | CID000023846 | |
| Drug | AalphaC | 3.88e-07 | 24 | 58 | 4 | CID000062805 | |
| Drug | AzMC | 4.61e-07 | 25 | 58 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 4.61e-07 | 25 | 58 | 4 | CID000004202 | |
| Drug | 2-pentanone | 4.61e-07 | 25 | 58 | 4 | CID000007895 | |
| Drug | alpha-methyldopamine | 5.43e-07 | 26 | 58 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 5.43e-07 | 26 | 58 | 4 | CID000115245 | |
| Drug | 1m2q | 5.43e-07 | 26 | 58 | 4 | CID005326637 | |
| Drug | Phosphoadenosine Phosphosulfate | 5.45e-07 | 7 | 58 | 3 | ctd:D010724 | |
| Drug | Glu-P-2 | 8.58e-07 | 29 | 58 | 4 | CID000049970 | |
| Drug | N-hydroxy-4-aminobiphenyl | 8.71e-07 | 8 | 58 | 3 | ctd:C014593 | |
| Drug | 3,3'-T2 | 9.89e-07 | 30 | 58 | 4 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 1.13e-06 | 31 | 58 | 4 | CID000122642 | |
| Drug | acetaminophen sulfate | 1.13e-06 | 31 | 58 | 4 | CID000083939 | |
| Drug | barium hydroxide | 1.13e-06 | 31 | 58 | 4 | CID000028387 | |
| Drug | DCNP | 1.47e-06 | 33 | 58 | 4 | CID000012066 | |
| Drug | carbodiimide | 2.35e-06 | 151 | 58 | 6 | CID000009864 | |
| Drug | mefenamic acid | 2.35e-06 | 37 | 58 | 4 | CID000004044 | |
| Drug | Viroisin | 2.55e-06 | 11 | 58 | 3 | CID000119538 | |
| Drug | bistheonellide A | 2.55e-06 | 11 | 58 | 3 | CID006441172 | |
| Drug | phenylhydroxylamine | 2.62e-06 | 38 | 58 | 4 | CID000007518 | |
| Drug | arabinosyladenine | AURKA PDE3B ACTBL2 ACTB PRKACA PRKACB ACTG1 NT5C3B UPF1 GABBR2 RYR1 | 2.98e-06 | 762 | 58 | 11 | CID000000191 |
| Drug | BFDGE | 3.40e-06 | 12 | 58 | 3 | CID000091511 | |
| Drug | d-equilenin | 3.58e-06 | 41 | 58 | 4 | CID000010597 | |
| Drug | KT5926 | 3.95e-06 | 42 | 58 | 4 | CID000122126 | |
| Drug | L-alpha-methyldopa | 3.95e-06 | 42 | 58 | 4 | CID000004138 | |
| Drug | magnesium | AURKA PDE3B ACTBL2 ACTB PRKACA PRKACB LAMA2 ACTG1 NT5C3B UPF1 CPS1 GABBR2 DICER1 RYR1 | 4.32e-06 | 1325 | 58 | 14 | CID000000888 |
| Drug | Woodward's reagent K | 4.34e-06 | 43 | 58 | 4 | CID000077804 | |
| Drug | manidipine | 4.37e-06 | 95 | 58 | 5 | CID000004008 | |
| Drug | NSC674039 | 4.77e-06 | 44 | 58 | 4 | CID000001249 | |
| Drug | 1IIg | 5.22e-06 | 45 | 58 | 4 | CID000001682 | |
| Drug | NDPS | 5.22e-06 | 45 | 58 | 4 | CID000090363 | |
| Drug | kabiramide C | 5.60e-06 | 14 | 58 | 3 | CID005288658 | |
| Drug | 4-octylphenol | 6.23e-06 | 47 | 58 | 4 | CID000015730 | |
| Drug | 5-hydroxymethylfurfural | 6.38e-06 | 2 | 58 | 2 | ctd:C008046 | |
| Drug | Hydroxytryptophol | 6.38e-06 | 2 | 58 | 2 | ctd:D006917 | |
| Drug | 6-hydroxymelatonin | 6.38e-06 | 2 | 58 | 2 | ctd:C012365 | |
| Drug | salicylamide | 6.78e-06 | 48 | 58 | 4 | CID000005147 | |
| Drug | sulfamethazine | 6.78e-06 | 48 | 58 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 6.78e-06 | 48 | 58 | 4 | CID000005896 | |
| Drug | Ro-1724 | 8.98e-06 | 110 | 58 | 5 | CID000005087 | |
| Drug | ITdU | 9.13e-06 | 292 | 58 | 7 | CID000000076 | |
| Drug | Rp-cAMPS | 9.92e-06 | 194 | 58 | 6 | CID006426631 | |
| Drug | 9-hydroxybenzo(a)pyrene | 1.01e-05 | 53 | 58 | 4 | CID000028598 | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 2860_UP | |
| Drug | androstenediol | 1.09e-05 | 54 | 58 | 4 | CID000010634 | |
| Drug | minoxidil | 1.09e-05 | 54 | 58 | 4 | CID000004201 | |
| Drug | dopamine | HDAC3 SULT1A2 PDE3B SULT1A4 SULT1A1 SULT1A3 ACTB ACTG1 GABBR2 RYR1 | 1.17e-05 | 715 | 58 | 10 | CID000000681 |
| Drug | MeIQx | 1.17e-05 | 55 | 58 | 4 | CID000062275 | |
| Drug | 8-azido cyclic AMP | 1.25e-05 | 18 | 58 | 3 | CID000115296 | |
| Drug | Nsc687160 | 1.25e-05 | 18 | 58 | 3 | CID005459290 | |
| Drug | orthovanadate | 1.38e-05 | 435 | 58 | 8 | CID000061672 | |
| Drug | noradrealine | 1.39e-05 | 575 | 58 | 9 | CID000000951 | |
| Drug | NSC36919 | 1.45e-05 | 58 | 58 | 4 | CID000235496 | |
| Drug | tolytoxin | 1.48e-05 | 19 | 58 | 3 | CID006440827 | |
| Drug | 5'IATR | 1.48e-05 | 19 | 58 | 3 | CID000074997 | |
| Drug | amiloride | 1.49e-05 | 315 | 58 | 7 | CID000016230 | |
| Drug | 4-hydroxyestrone | 1.55e-05 | 59 | 58 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.55e-05 | 59 | 58 | 4 | CID000083944 | |
| Drug | AC1L1B55 | 1.88e-05 | 454 | 58 | 8 | CID000001287 | |
| Drug | 5-hydroxy-3-methylindole | 1.91e-05 | 3 | 58 | 2 | CID000192734 | |
| Drug | PCI-24781 | 1.91e-05 | 3 | 58 | 2 | CID011749858 | |
| Drug | trapoxin B | 1.91e-05 | 3 | 58 | 2 | ctd:C067071 | |
| Drug | 5-hydroxyindole | 1.91e-05 | 3 | 58 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.91e-05 | 3 | 58 | 2 | ctd:D008914 | |
| Drug | 8-azaadenine | 1.91e-05 | 3 | 58 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 1.91e-05 | 3 | 58 | 2 | ctd:C030629 | |
| Drug | genistein | ZC3H10 SULT1A2 CLCN6 SULT1A1 ACTBL2 ACTB PRKACA PRKACB LAMA2 ACTG1 RYR1 CACNA2D3 | 2.01e-05 | 1117 | 58 | 12 | CID005280961 |
| Drug | 3-OHBaP | 2.02e-05 | 63 | 58 | 4 | CID000025890 | |
| Drug | tyramine | 2.02e-05 | 130 | 58 | 5 | CID000005610 | |
| Drug | AC1L8NVR | 2.02e-05 | 21 | 58 | 3 | CID000384633 | |
| Drug | Mgamp-pnp | 2.02e-05 | 21 | 58 | 3 | CID005311323 | |
| Drug | NSC312786 | 2.02e-05 | 21 | 58 | 3 | CID000329495 | |
| Drug | 4-nonylphenol | 2.15e-05 | 64 | 58 | 4 | CID000001752 | |
| Drug | epicatechin-3-gallate | 2.29e-05 | 65 | 58 | 4 | CID000065056 | |
| Drug | NSC611747 | 3.04e-05 | 352 | 58 | 7 | CID000002534 | |
| Drug | 1-nitronaphthalene | 3.06e-05 | 24 | 58 | 3 | ctd:C016614 | |
| Drug | Nbd-Ph | 3.06e-05 | 24 | 58 | 3 | CID004682184 | |
| Drug | Pyrethroids | 3.24e-05 | 71 | 58 | 4 | CID000005053 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 7.70e-07 | 10 | 56 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.70e-07 | 10 | 56 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 3.54e-06 | 2 | 56 | 2 | C1855722 | |
| Disease | Baraitser-Winter syndrome | 3.54e-06 | 2 | 56 | 2 | cv:C1853623 | |
| Disease | Fryns-Aftimos Syndrome | 3.54e-06 | 2 | 56 | 2 | C1853623 | |
| Disease | Uveoretinal Coloboma | 7.38e-05 | 7 | 56 | 2 | C4554007 | |
| Disease | Congenital ocular coloboma (disorder) | 1.26e-04 | 9 | 56 | 2 | C0009363 | |
| Disease | Congenital neurologic anomalies | 1.58e-04 | 10 | 56 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.58e-04 | 10 | 56 | 2 | C0265541 | |
| Disease | Congenital muscular dystrophy | 2.31e-04 | 12 | 56 | 2 | cv:C0699743 | |
| Disease | X-12707 measurement | 2.31e-04 | 12 | 56 | 2 | EFO_0800720 | |
| Disease | ascorbic acid 3-sulfate measurement | 3.17e-04 | 14 | 56 | 2 | EFO_0800173 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.66e-04 | 15 | 56 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Autosome Abnormalities | 4.17e-04 | 16 | 56 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 4.17e-04 | 16 | 56 | 2 | C0008625 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.19e-04 | 195 | 56 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Intrahepatic Cholangiocarcinoma | 9.51e-04 | 24 | 56 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 9.51e-04 | 24 | 56 | 2 | C3805278 | |
| Disease | pallidum volume change measurement, age at assessment | 1.03e-03 | 25 | 56 | 2 | EFO_0008007, EFO_0021494 | |
| Disease | Cholangiocarcinoma | 1.12e-03 | 26 | 56 | 2 | C0206698 | |
| Disease | congestive heart failure (is_implicated_in) | 1.20e-03 | 27 | 56 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | putamen volume | 1.59e-03 | 31 | 56 | 2 | EFO_0006932 | |
| Disease | RS-warfarin measurement | 1.87e-03 | 128 | 56 | 3 | EFO_0803325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYLVEDSLYPHFTLL | 136 | Q2TAA5 | |
| ELTALLHHYYPIEID | 76 | Q969T7 | |
| HDATRVYLILEYAPL | 201 | O14965 | |
| IYEGYALPHAILRLD | 166 | Q562R1 | |
| YEGYALPHAILRLDL | 166 | P60709 | |
| YEGYALPHAILRLDL | 166 | P63261 | |
| RDYLILRPHDIAYLL | 261 | Q9Y3Q7 | |
| EELYRLDSLHPDLIY | 166 | Q9BR76 | |
| ILDYLITKHLYEDPR | 1711 | Q9UPY3 | |
| YLLPDEIYSELQEAH | 81 | Q9NZA1 | |
| DLDSYIPLHEDLLTR | 221 | Q7Z628 | |
| TRYESLLENLDDHYP | 91 | Q8WYQ4 | |
| EYLHSLDLIYRDLKP | 156 | P17612 | |
| LYPHLYEDALIDEVE | 386 | Q8N7X4 | |
| FELRELDPEAHTYIL | 546 | Q9HCI5 | |
| ELDQYHLYLPLIQER | 2041 | Q9Y3R5 | |
| ERSLHRAPYYLLLDL | 46 | Q9NS67 | |
| LYLSRPEYNFLLHLD | 861 | Q13370 | |
| LDHDYSRYFPIIDEL | 131 | Q7Z3Y8 | |
| LDHDYSRYFPIIDDL | 126 | Q7Z3Z0 | |
| REDFLDILYDIHYIL | 1326 | P24043 | |
| HVSLLDRLYEHYPAE | 841 | P42694 | |
| ELLKYHPRVLYIDID | 156 | O15379 | |
| DDYLYSLCSEPLIEL | 106 | A2A3N6 | |
| DEEPQHVLLRYEDAY | 286 | Q92900 | |
| PRSLHNYLLYEDVLR | 491 | Q9Y575 | |
| YFEELSLERILDIYH | 1031 | P31327 | |
| YPRYPDIHDLDLTLL | 781 | P51797 | |
| EYLHSLDLIYRDLKP | 156 | P22694 | |
| QPRLLDILSEHLYYD | 751 | O14981 | |
| DILSEHLYYDEIAVP | 756 | O14981 | |
| GYILTHPELRLLYEE | 531 | Q8IZS8 | |
| SLLIRHVLEEDIGYY | 751 | Q8TD84 | |
| RDYLLPDVHDSVLYR | 131 | F2Z333 | |
| FEYHRYPELREALVS | 51 | P16870 | |
| ESLLRPYFLDLRLYD | 91 | O75899 | |
| LHYYPLEEVLTAEYL | 441 | P14735 | |
| EDDPSVLYVSLHRYD | 661 | Q9UBN7 | |
| LRAGYYDLLISIHLE | 1706 | P21817 | |
| TLLDLVYLLHEPIYE | 211 | Q8N815 | |
| VYLLHEPIYESLLRA | 216 | Q8N815 | |
| YYHILRADLLPPEER | 301 | Q9BQ95 | |
| YLEHYLDSIENLPFE | 6 | Q9UNL4 | |
| RLYIIYHLPGVELLD | 156 | A6NJI9 | |
| HLYITKELEHYPLER | 486 | O94851 | |
| YSLIDHDYIPREIDR | 411 | Q8N323 | |
| VPLLDSYDLLSYDDL | 701 | A2RUB1 | |
| LILLLELYSPRDVYD | 766 | Q8TF05 | |
| LSDLLRFVEEDHIPY | 231 | Q53T94 | |
| FLDHPEIYRSFLEIL | 176 | O75182 | |
| EEIYPYIRTLLHFDT | 771 | Q8N3P4 | |
| LRLFEYLHESLYNPE | 111 | Q8N5J4 | |
| HLYLLPYENLLTEDE | 576 | Q12769 | |
| DLLHRTAPLLLSYYL | 761 | Q12769 | |
| ELSRTHPVLYLFYED | 181 | P0DMN0 | |
| ELSRTHPVLYLFYED | 181 | P0DMM9 | |
| ELSRTHPVLYLFYED | 181 | P50225 | |
| ELSRTHPVLYLFYED | 181 | P50226 | |
| ETHYPDIYTREELAL | 111 | O14813 | |
| LDRHDPSLPYLEQYR | 851 | Q6ZT07 | |
| RDHLYLPLEPSYRES | 146 | Q12968 | |
| YEIYLTLHKPEDVRL | 476 | Q6ZN44 | |
| VLPGRRHDLYDIYDL | 181 | Q96K80 |